baber/WOPTO huggingface dataset:
Patent PT-1624761-E (PT)
Title: Method and inoculum for acidifying lactic fermentation
Inventor: MARCHAL LAURENT
IPC: A23C9/123
Filed: 2004-05-07
Abstract: Inoculum for direct inoculation into a dairy substrate to convert the substrate to a fermented dairy food comprises a yeast lysate and lactic acid bacteria in the form of a mixture or kit. There are 2 X 10 8>to 2 X 10 1>3>lactic acid bacteria per gram of yeast lysate. An independent claim is also included for producing fermented dairy foods by adding up to 0.6 g/l of a yeast lysate to a pasteurized dairy substrate before lactic fermentation so that there are 2 X 10 8>to 2 X 10 1>3>lactic acid bacteria per gram of yeast lysate.
Patent PT-1672974-E (PT)
Title: Device for separating off parts of a plant branch
Inventor: ROMBOUTS PETER KAREL MARIA
IPC: A01G3/00
Filed: 2004-09-30
Abstract: Device and installation (40) for separating cuttings off a plant branch which is suspended from a carrier, having a processing station (2) and a unit which forms an image of the branch, and having carrier feed means for presenting a carrier (28) with a branch (24) suspended from it at a first, high level and lowering the position of the branch (24) to a second, lower finishing level in steps via intermediate phases, wherein a section of the branch (24) which is to be processed can be evaluated by the assessing unit successively in each intermediate phase, and the installation (40) comprises a device of this type having a first, low conveyor track (54) for branch carriers (28) and a higher conveyor track (56), which is connected to the first conveyor track via a rising track (58), the vertical distance between the two conveyor tracks substantially corresponding to the distance between the high level and the low level at the processing station.
Patent PT-1873325-E (PT)
Title: Interior decoration system
Inventor: ROTTIERS ALEX
IPC: E04F13/06
Filed: 2006-06-28
Abstract: A doorjamb (10; 30), comprising a body (21; 22) shaped for enclosing a wall part adjacent to a door opening, the body (21; 22) being constructed in a reinforced wall plastering material.
Patent PT-1814139-E (PT)
Title: Disc-shaped cathode screen adapted to a compact fluorescent lamp
Inventor: AXELSSON FOLKE
IPC: H01J61/10
Filed: 2007-01-22
Abstract: Compact fluorescent lamp comprising a fluorescent lamp body (3), a cathode space (9) comprising a screened space (11) around an electrode (5) arranged inside the compact fluorescent lamp (1), and a power supply device (19) so arranged as to provide an electrical connection between the electrode (5) and a contact device (21) positioned next to the contact end (13) of the compact fluorescent lamp.  The screened space (11) is formed by the electrode (5) enclosing the internal wall (7) of the fluorescent lamp body (3) and by a neighbouring electrode (5) and beyond it a disc-shaped cathode screen (15) in a direction away from the contact end (13) containing a central opening (17).
Patent PT-2007469-E (PT)
Title: Drop dispenser for the delivery of uniform droplets of viscous liquids
Inventor: BOWMAN LYLE M
IPC: A61F9/00
Filed: 2007-03-28
Abstract: A drop dispenser has a substantially conical sleeve member with a narrow upper end and a wide lower end. Centrally located at the apex of the upper end of the sleeve member is an aperture which has an inner diameter and is circumscribed by a raised ridge. The aperture and the ridge form a nozzle. The interior space of the substantially conical sleeve member forms a substantially conical chamber between the narrow upper end and wide lower end of the sleeve member. The nozzle is in liquid communication with the chamber through the aperture. The drop dispenser may have external threads at the lower end of the sleeve member for engaging a cap having a protuberance centrally located at its internal top end for hermetically engaging the aperture of the nozzle when the cap fully engages the sleeve member.
Patent PT-2197935-E (PT)
Title: Stabilization of polyurethane foam polyol premixes containing halogenated olefin blowing agents
Inventor: WILLIAMS DAVID J
IPC: C08G18/08
Filed: 2008-10-06
Abstract: The invention provides polyurethane and polyisocyanurate foams and methods for the preparation thereof More particularly, the invention relates to open-celled, polyurethane and polyisocyanurate foams and methods for their preparation. The foams are characterized by a fine uniform cell structure and little or no foam collapse. The foams are produced with a polyol premix composition which comprises a combination of a hydrohaloolefin blowing agent, a polyol, a silicone surfactant, and a catalyst which is an adduct of an amine and an organic acid.
Patent PT-2280965-E (PT)
Title: Thiazol-4-carboxylic acid esters and thioesters as plant protection agents
Inventor: WACHENDORFF-NEUMANN ULRIKE
IPC: A01N43/78
Filed: 2009-04-18
Abstract: The use of thiazole-4-carboxylic esters and thioesters of the formula (I) in which R1, R2, R3, R4, R5, R6, R7, Y1, Y2, Y3, W, X and G have the meanings given in the description, and also of agrochemically active salts thereof, as fungicides.
Patent PT-767826-E (PT)
Inventor: CRUTZEN ANDRE
IPC: C11D1/83
Filed: 1995-06-08
Abstract: An anionic fabric softening emulsion composition containing a pentaerythritol softener, an anionic emulsifying agent, and, optionally, a nonionic emulsifier.
Patent PT-747389-E (PT)
Inventor: MATSUDA AKIRA
IPC: C07H19/06
Filed: 1995-12-13
Abstract: The invention relates to a 3'-substituted nucleoside derivative represented by the following general formula (1): <CHEM> wherein B means a nucleic acid base which may have a substituent, Z represents a lower alkynyl or lower alkenyl group which may be substituted by a group represented by the formula: <CHEM> in which R<a>, R<b> and R<c> are individually a lower alkyl group or a phenyl group, or an oxiranyl group which may have at least one lower alkyl group, R<1> and R<2> individually represent H or an ester-forming residue capable of easily leaving in a living body, and R<3> is H, a mono- or polyphosphoric acid residue, or an ester-forming residue capable of easily leaving in a living body, with the proviso that the sugar moiety is ribose, or a pharmaceutically acceptable salt thereof. The 3'-substituted nucleoside derivative according to the invention has an excellent antitumor activity and is hence useful for treatment for and prevention of cancers.
Patent PT-836482-E (PT)
Inventor: IVY JOHN M
IPC: A61K39/00
Filed: 1996-05-24
Abstract: The Flaviviridae comprise a number of medically important pathogens that cause significant morbidity in humans including the dengue (DEN) virus, Japanese encephalitis (JE) virus, tick-borne encephalitis virus (TBE), and yellow fever virus (YF). Flaviviruses are generally transmitted to vertebrates by chronically infected mosquito or tick vectors. The viral particle which is enveloped by host cell membranes, comprises a single positive strand genomic RNA and the structural capsid (CA), membrane (M), and envelope (E) proteins. The E and M proteins are found on the surface of the virion where they are anchored in the membrane. Mature E is glycosylated and contains functional domains responsible for cell surface attachment and intraendosomal fusion activities. Problems have arisen in the art with respect to producing recombinant forms of the E glycoprotein that retain their native configuration and attendant properties associated therewith (i.e., ability to induce neutralizing antibody responses). To date, recombinantly produced E glycoproteins have suffered from a number of limitations including improper glycosylation, folding, and disulfide bond formation. The claimed invention has addressed these concerns by providing secreted recombinant forms of the E glycoprotein that are highly immunogenic and appear to retain their native configuration. Carboxy-terminally truncated forms of E containing the amino terminal 395 amino acids and a suitable secretion signal sequence were generated in Drosophila melanogaster Schneider cell lines. Immunogenic compositions comprising these recombinant envelope glycoproteins were capable of inducing protective, neutralizing antibody responses when administered to a suitable host.
Patent PT-835258-E (PT)
Inventor: BIGG DENNIS
IPC: C07D487/04
Filed: 1996-06-21
Abstract: Camptothecin analogues where the camptothecin hydroxy lactone is: (i) a  beta -hydroxy lactone; or (ii) the corresp.  beta -hydroxy acid resulting from ring-opening of the aforementioned lactone; or a (iii) deriv. of the  beta -hydroxy acid in (ii) or its one of its salts. Also claimed are new industrial prods. of formula (M) and (A). R1 = lower alkyl, lower alkenyl, lower alkynyl, halo(lower alkyl), lower alkoxy(lower alkyl) or lower alkylthio(lower alkyl); R20 = H or halo; R22 = F, Cl, or lower alkoxy; R23 = prim. hydroxy-protecting gp.; and R18, R19 = H, halo, lower alkyl, lower alkoxy or OH.
Patent PT-1030642-E (PT)
Inventor: SCHOLZ WOLFHARD
IPC: A61Q15/00
Filed: 1998-10-30
Abstract: An improved stick preparation is provided which is made up of at least two separate phases and at least one phase contains spherical polymer particles which can contain a pigment. The particles provide smoothness to the preparation and can be used to provide an interesting visual appearance to the stick.
Patent PT-1103800-E (PT)
Inventor: POMARES JAIME SANTANA
IPC: B44D3/00
Filed: 1999-08-05
Abstract: An objective color nomenclature generator which consists of a set of 361 pieces made of a flexible material, preferably of a plane rectangular shape (1), having a longitudinal and a transverse stripe forming a gridded surface, presenting different columns on its surface in which digits and tonalities are incorporated which correspond to proportional quantities of mixtures, as well as the quantities corresponding to the basic and complementary colors, including lightness with respect to white or darkness with respect to black, varying between 0 and 100. <IMAGE>
Patent SG-92984-G (SG)
Title: Electrical connector for multiconductor flat insulated cable
IPC: H01R4/24
Filed: 1984-12-28
Abstract: An adaptation for a series «D» type connector in which the terminals (12) have an initial center spacing greater than the conductor spacing of a multiconductor flat insulated cable (30) to be terminated whereby the terminal center specing coincides with the conductor center spacing.
Patent IE-34859-L (IE)
Title: Isoquinolines.
IPC: C07D217/18
Filed: 1971-01-04
Abstract: 1335261 Isoquinolines HOFFMANN-LA ROCHE & CO AG 5 Jan 1971 [6 Jan 1970] 454/71 Heading C2C Compounds of the general formula (R = OH, C 1-4 alkoxy; R 1 = H, OH, C 1-4 alkoxy or R + R 1 = OCH 2 O; R 2 = H, C 1-4 alkyl; R 3 = C 1-4 alkyl, Ph(C 1-4 alkyl); R 4 = halogen, NO 2 NH 2 , C 1-4 alkylamino, di-(C 1-4 alkyl)amino; n = 1,2) and their acid addition salts are prepared by (a) cyclizing a compound of the formula (X = OH, acyloxy, halogen), (b) alkylating or aralkylating a compound of the formula (R 40 = halogen, NO 2 , dialkylamino), (c) reducing a compound of the formula (R 0 = C 1-4 alkoxy; R 10 = H, C 1-4 alkoxy or R 0 + R 10 = OCH 2 O; R 30 = C 1-4 alkyl, Ph(C 2-4 alkyl); R 41 = halogen, dialkylamino) under acidic conditions or reducing a compound of the formula (d) reducing a compound of the formula (R 11 = OH, C 1-4 alkoxy or R + R 11 = OCH 2 O; Y = anion), (e) reducing a compound of the formula (f) when R and/or R 1 = OH, subjecting a corresponding compound in which R and/or R 1 = alkoxy to acidic ether-cleavage, (g) when R 4 = NH 2 (R 3 not PhCH 2 ), reducing a corresponding compound in which R 4 = NO 2 , (h) when R 4 = alkylamino or dialkylamino, monoalkylating a corresponding compound in which R 4 = NH 2 or alkylamino, (i) when R and/or R 1 = OH (R 3 not PhCH 2 , R 4 not NO 2 ), hydrolytically debenzylating a corresponding compound but in which R and/or R 1 = PhCH 2 O, (j) when the product is optically active, resolving the racemate or using an optically active starting material or (k) when the product contains at least two asymmetric carbon atoms, separating an individual racemate from the diastereomer mixture, optionally followed in each case by salt formation. The starting materials are prepared by the following routes The above compounds are antidepressants, and may be administered in the form of pharmaceutical preparations containing them in association with a carrier.
[GB1335261A]
Patent IE-35990-L (IE)
Title: Thiazoline azetidinones
IPC: C07D501/10
Filed: 1972-01-18
Abstract: Novel 2-substituted thiazoline azetidinones are obtained from 2,6-disubstituted thiazoline azetidinones by treatment with lead tetraacetate followed by hydrolysis. The novel 2-substituted thiazoline azetidinones are reduced by treatment with aluminum amalgam or sodium borohydride to the corresponding thiazolidine azetidinones which are useful in the synthesis of penicillins and cephalosporins.
[US3681380A]
Patent IE-800244-L (IE)
Title: Two-part adhesive composition
IPC: C09J4/06
Filed: 1980-02-08
Abstract: A structurally toughened heat resistant adhesive composition comprising a solution of a polyacrylic elastomer in polymerizable acrylate ester monomers. The adhesive composition also contains an adhesion promoter, a cross-linking agent, a free-radical generator and a free-radical accelerator. The adhesive compositions are generally used as two-part systems, and yield bonds with improved heat and solvent resistant properties. The polymerizable acrylate ester monomers may be monofunctional or a combination of mono- and polyfunctional monomers. Among the useful classes of monomers are alkyl and cycloalkyl acrylates, alkyl and cycloalkyl methacrylates, alkoxy acrylates and methacrylates, alkylene diacrylates and dimethacrylates. A few of the preferred monomers are methyl methacrylates, lauryl methacrylates, isobornyl methacrylates, and tetrahydrofurfuryl methacrylates. The preferred acrylic rubbers are generally the homopolymers of alkyl esters of acrylic or methacrylic acid; homopolymers of alkoxy esters of acrylic or methacrylic acid; or copolymers of either of these with a lower alkene. Most preferred are the rubbers formed from the copolymerization of ethyl acrylate with 2-chlorethyl vinyl ether, or from the copolymerization of ethylene, methyl acrylate and a third monomer containing carboxylic curing sites.
[US4442267A]
Patent IE-34274-L (IE)
Title: Detergent compositions
IPC: C11D3/44
Filed: 1970-06-09
Abstract: 1318184 Wash powder UNILEVER Ltd 9 June 1970 [13 June 1969] 30245/69 Heading C5D A washing powder composition comprises (a) 5-40% of a non-ionic surface active agent including 5-15 ethylene oxide residues per hydrophobic group, (b) 25-80% of a builder and (c) 1-35% of a non-toxic liquid substituted aromatic compound, the quantity of surface active agent being greater than that of aromatic liquid and any carrier for the aromatic liquid being calculated as part of component (c). Ingredients specified include surface active agents (a): ethylene oxide adducts of secondary alcohols, oxo-alcohols, branched nonyl phenol and tallow fatty acid amide and a fatty alcohol/ propylene oxide/ethylene oxide adduct, builders: sodium tripolyphosphate, alkaline sodium silicate, sodium carbonate, and sodium orthophosphate, aromatic liquids: disubstituted benzenes in which one substituent is alkyl-, alkoxy- and alkoxycarbonyl-substituted naphthalenes, alkyl, alkoxy or alkoxycarbonyl derivatives of diphenyl methane, a diphenyl ethane, diphenyl ether, or benzophenone, dibutyl phthalate, diethyl phthalate, dimethyl phthalate, diheptyl isophthalate, dinonyl phthalate, dipropyl isophthalate, dipropyl phthalate, diisoheptyl phthalate, dibutyl isophthalate, diethyl benzene, benzophenone, diphenylmethane, diphenyl ether, benzyl butyl ether, dibenzyl ether, octafluoro toluene, 1-methyl naphthalene, 2-methyl naphthalene, diphenyl methane, 1,2- diphenyl ethane, triethyl benzene, cumene, di-isopropyl benzene, 1,2,4-trimethyl benzene, p-cymene and 1-chloronaphthalene, carrier: an aluminosilicate, others: sodium coconut soap, sodium tallow soap, monostearyl phosphate, palm kernel fatty acid ethanolamide, sodium sulphate, sodium perborate, magnesium silicate, sodium carboxymethyl cellulose, methyl cellulose, sodium toluene sulphonate, enzymes, brighteners, perfume and water.
[GB1318184A]
Patent IE-41402-L (IE)
Title: Closure bushing
IPC: B65D47/10
Filed: 1974-04-23
Abstract: A closure bushing molded of synthetic plastic material having an internally threaded cylindrical wall terminating at one end in a laterally extending octagonally shaped flange. The other end of the cylindrical wall is closed off by a tamperproof sealing diaphragm bordered by a circumferential weakened tearing zone and having a center panel recessed within the bushing interior.
[US3802027A]
Patent IE-870990-L (IE)
Title: Topical antimicrobial compositions
IPC: A61P31/04
Filed: 1987-04-15
Abstract: The present invention discloses a topical antimicrobial pharmaceutical composition comprising an ethoxylated or propoxylated glyceryl fatty acid ester and a pharmaceutically acceptable carrier, the composition also optionally comprising a mixture of fatty acids including a first C6-18fatty acid antimicrobial agent and a second C6-18fatty acid antimicrobial agent; the compositions may also comprise a glyceryl fatty acid and a mixture of fatty acids; the compositions are useful in treating and preventing microbial-related skin conditions in humans or animals by topical application.
[EP0243145A2]
Patent FI-823844-L (FI)
Inventor: THOMAS CHRISTIAN
IPC: H01H71/68
Filed: 1982-11-09
Abstract: A contactor apparatus is provided comprising automatic opening means and a local control member. This apparatus uses a transmission piece (40) associated with a sudden tripping mechanism (46) which is released by a bolt (29) held in position by means of a lever (24) which may be struck by a magnetizable part and adapted to maintain a power contact (13) open, this part assuming, after the appearance of a fault, visible positions so as to inform the user about the state of the apparatus. This apparatus is usable in installations where it is desired to protect the lines and the loads.
Patent IE-841055-L (IE)
Title: Pharmaceutical product in bandage form
IPC: A61L15/16
Filed: 1984-04-27
Abstract: The present invention is related to a pharmaceutical product preferably in medical bandage form, for the controlled release of a therapeutically active agent or several such agents to the skin. The pharmaceutical product of the invention consists of an impermeable backing layer, a particularly composed supersaturated reservoir layer for the therapeutically active agent connected therewith and comprising a polymer matrix wherein the therapeutically active agent is soluble and which is permeable to the active agent, an adhesive layer connected with the reservoir layer and permeable to said adhesive layer and removable therefrom for the use of the pharmaceutical product as transdermal therapeutic system, said reservoir layer for the therapeutically active agent consisting of a multitude of layers wherein the concentration of the therapeutically active agent increases from layer to layer with increasing distance from the adhesive layer, and process for producing such a pharmaceutical product.
[EP0144486A2]
Patent IE-791085-L (IE)
Title: Implement for working crop lying on the ground
IPC: A01D51/00
Filed: 1979-08-08
Abstract: A hay machine for working crop lying on the ground, such as a side-delivery rake, a tedder or a combined hay-making machine has a tined carrier for redepositing worked crop on the ground and comprises rows of tines which, in operation, are rotated in a forward direction while being turned oppositely over at least part of their path near the ground. The tines, which are located near the ground, extend horizontally and in a forward direction with respect to the direction of machine movement. The carrier preferably mounts three rows of elongated tines that are each shaped as a lazy S and pointed at each end. A sun wheel and planet gear system drives the carrier as a whole while turning the tines to pick up crop, raise and deposit same to the rear of the carrier. The orientation of the tines can be adjusted by displacing the sun wheel relative to the frame and fixing same in position. A crop crusher is mounted adjacent the paths of the tines and spring means urges the crusher to adjusted positions in which crop is intersepted and worked further.
[US4287710A]
Patent IE-36809-L (IE)
Title: Glucocorticoid-like water diuretic.
IPC: C07D491/18
Filed: 1972-10-26
Abstract: 1358136 Compositions comprising decinine SMITHKLINE CORP 8 Nov 1972 [11 Nov 1971] 51549/72 Heading A5B A pharmaceutical composition, in dosage unit form, comprises a pharmaceutical carrier and decinine.
[GB1358136A]
Patent IE-891502-L (IE)
Title: Solvent-based alkyd paints
IPC: C09D167/00
Filed: 1989-05-09
Abstract: The paint has a creamy non-resilient structure of at least 60 gm. cm. seven days after manufacture induced by the use of interacting resins together with a clay-based rheology modifier.
Patent IE-43939-L (IE)
Title: Selective combating of weeds
IPC: C07C69/67
Filed: 1976-08-20
Abstract: Herbicidal compositions containing (1) 3-methyl-4-amino-6-phenyl-1,2,4-triazin-5-one of the formula  and (2) a 4-phenoxy-phenoxy-alkanecarboxylic acid derivative of the general formula  wherein R and R1 may be hydrogen or halogen N AND N1 ARE INTEGERS FROM 1 TO 3 R2 is hydrogen or alkyl R3 is hydrogen or alkyl or a cation DISPLAY OUTSTANDING SYNERGISTIC EFFECTS WHEN APPLIED AS HERBICIDES. (From US4047929 A) [FR2321239A1]
Patent IE-901872-L (IE)
Title: Stable phenytoin prodrug insection
IPC: A61K47/16
Filed: 1990-05-24
Abstract: Described is a stable pharmaceutical composition of 3-(hydroxymethyl-5,5-diphenylhydantoin disodium phosphate ester, the prodrug of 5,5-diphenylhydantoin (phenytoin) a commonly used drug for the treatment and management of epilepsy and other types of convulsive states. It has been found that degradation of the prodrug to phenytoin can be controlled by controlling the pH of the composition. Controlling the pH to between 8.3 to 9.4 results in the production of diphenylglycinamide as the primary degradant and minimization of degradation to phenytoin. If the pH is maintained at a lower or higher value, then the degradation pattern changes, with earlier than expected product failure.
Patent IE-862503-L (IE)
Title: Sulphonamide derivatives
IPC: C07D319/18
Filed: 1986-09-19
Abstract: This invention provides sulfonamide derivatives useful in the treatment of susceptible neoplasms in warm-blooded animals of formula (I): <CHEM> in which A is -O-, -@CH3, -CH2-, -CH2CH2-, or -CH2O-; D is -CH2- or -O-; R1 is hydrogen or halo, and R2 is halo or trifluoromethyl. E.g., N-([(4-chlorophenyl)amino]carbonyl)-2,3-dihydro-1H-indene-5-sulfonamide, m.p. 169-172 DEG C, is prepared by reacting 2,3-dihydro-5-indenylsulfonamide with 4-chlorophenylisocyanate.
[EP0222475A1]
Patent IE-40791-L (IE)
Title: Vincamine derivatives
IPC: A61P25/28
Filed: 1974-12-16
Abstract: 1492579 Vincamine derivatives SANDOZ Ltd 16 Dec 1974 [18 Dec 1973 6 Feb 1974 8 Feb 1974] 54159/74 Heading C2C Novel compounds I (in which R 1 is Br, F, Cl, OH, or 1-40 alkyl or alkoxy with the proviso that when R 1 is in the 11- or 12-position it is other than -OCH 3 ) are prepared (a) by cyclization of a compound II (in which R 2 is 1-4C alkyl) in the presence of acid; (b) by reaction of a compound III at less than 0‹ C. with a hydrogen halide, followed by hydrolysis or (c) by bromination of vincamine to give the 11-bromo derivative. Compounds II are prepared by reaction of a compound IV with a compound V to give a compound VI reaction of the compound VI with imidazole to give a compound VII treatment of the compound VII with acid to give a compound VIII reaction of the compound VIII with a compound IX to give a compound X Bischler-Napieralski ring closure of the compound X to give a compound XI and reduction of the compound XI. Pharmaceutical compositions exhibiting vigilance-increasing and psychostimulation activity comprise a compound I or a pharmaceutically acceptable acid addition salt thereof together with a suitable excipient and are administered orally or parenterally.
[GB1492579A]